[Treatment of thrombocytopenic thrombotic purpura].
Corte Buelga
J R
JR
Hospital Central de Asturias, Centro Universitario.
Rodríguez Vicente
P
P
García Gala
J M
JM
Alonso García
A M
AM
Martínez Revuelta
E
E
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001803:Blood Transfusion; D002648:Child; D003131:Combined Modality Therapy; D006463:Hemolytic-Uremic Syndrome / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010949:Plasma; D010951:Plasma Exchange; D010956:Plasmapheresis; D010974:Platelet Aggregation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000145:classification / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D016879:Salvage Therapy; D013156:Splenectomy
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors